Projects per year
Personal profile
Diplomas
Areas of expertise
Awards
Alfers Prize 2022
Namurois de l'année 2019
Eberhard F. Mammen - Young Investigator Award 2019
Prix Léo Pharma 2017 - Cancer et Thrombose
XXIV Congress of the International Society on Thrombosis and Haemostasis - Young Investigator Award
58th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis - Young Investigator Award
55th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
56th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
Education/Academic qualification
Doctor of Pharmacy, University of Namur
Award Date: 24 Oct 2015
Master of Pharmacy, Université Catholique de Louvain
Award Date: 24 Jun 2011
Bachelor of Pharmacy, University of Namur
Award Date: 4 Sept 2009
External positions
Member of the Expert Team Haemostasis Diagnostics, ECAT Foundation
Nov 2019 → …
Chief Executive Officer, Qualiblood
Nov 2017 → …
Co-Chairman, International Society on Thrombosis and Haemostasis
Nov 2016 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Jonathan Douxfils is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GT4Health: AAV and the hemostatic system
Michaux, P. (PI), Douxfils, J. (Supervisor) & Bouarroudj, H. (Researcher)
1/09/24 → 30/06/28
Project: PHD
-
NeutroLab project: Exploring neutrophil dynamics and NETosis in health and disease
Gillot, C. (PI), Michaux, P. (Researcher), Douxfils, J. (PI), Debroux, M. (Technician) & Bouarroudj, H. (Researcher)
1/01/24 → …
Project: Research Axis
-
NucleoGlio (BioWin): Development of a diagnostic test for glioblastoma and follow-up of patients
Douxfils, J. (PI)
1/11/23 → 31/10/27
Project: Research
-
PALPITATION: The platelet lipidome, a promising diagnostic or therapeutic option for HFpEF patients
Horman, S. (PI), POULEUR, A.-C. (CoPI), Dessy, C. (CoPI) & Douxfils, J. (CoPI)
1/10/23 → 30/09/28
Project: Research
-
Abelacimab and osocimab: Pharmacodynamic insights from coagulation assays
Vassart, J., Minguet, R., Brisbois, C. & Douxfils, J., 2 Mar 2026, p. 138-140.Research output: Contribution to conference › Poster
File20 Downloads (Pure) -
Abelacimab and osocimab: What impact on laboratory coagulation assays?
Vassart, J., Minguet, R., Brisbois, C. & Douxfils, J., 2 Mar 2026, p. 137-138.Research output: Contribution to conference › Poster
File23 Downloads (Pure) -
A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception
Gaspard, U., Chatel, G., Douxfils, J. & Stanczyk, F. Z., 26 Mar 2026, In: Frontiers in endocrinology. 17, p. 1730768Research output: Contribution to journal › Review article › peer-review
Open AccessFile55 Downloads (Pure) -
A Point-of-Care System for the Quantification of Small-Molecule Drugs in Blood
Hansen-Bruhn, M., Nielsen, L. D. F., Mortensen, M., Vinther, J., Spring, M. K., Villadsen, N., Jeminejs, A., Comuth, W., Lynggaard, V., Böttcher, M., Kristensen, S. D., Douxfils, J., van de Kerkhof, D., Münster, A.-M. B., Møller, H. J. & Gothelf, K. V., 2 Jul 2026, (E-pub ahead of print) In: ACS sensors.Research output: Contribution to journal › Article › peer-review
Open AccessFile41 Downloads (Pure) -
Cardiovascular Safety: The Point of View of the Veins
Douxfils, J. & Beaudart, C., 2026, Ethical, Efficacy and Safety Issues in Contraception. Springer, C. (ed.). p. 189-215 27 p. (Reproductive Medicine for Clinicians).Research output: Contribution in Book/Catalog/Report/Conference proceeding › Chapter
1 Downloads (Pure)
Datasets
-
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause
Gérard, C. (Creator), Arnal, J.-F. (Creator), Jost, M. (Creator), Douxfils, J. (Creator), Lenfant, F. (Creator), Fontaine, C. (Creator), Houtman, R. (Creator), Archer, D. F. (Creator), Reid, R. L. (Creator), Lobo, R. A. (Creator), Gaspard, U. (Creator), Bennink, H. J. T. C. (Creator), Creinin, M. D. (Creator) & Foidart, J.-M. (Creator), Taylor & Francis, 2022
DOI: 10.6084/m9.figshare.19430354
Dataset
-
Supplemental data Long-term kinetics anti-SARS-CoV-2 Favresse 2020
Favresse, J. (Creator), Elsen, M. (Creator), Eucher, C. (Creator), Laffineur, K. (Creator), Eeckhoudt, S. V. (Creator), Jean-Baptiste Nicolas (Creator), Gillot, C. (Creator), Jean-Michel Dogné (Creator) & Douxfils, J. (Creator), Unpublished, 2020
DOI: 10.13140/rg.2.2.11696.38408
Dataset
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
55th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, J. (Recipient), 7 Dec 2013
Prize: Prize (including medals and awards)
-
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, J. (Recipient), 6 Dec 2014
Prize: Prize (including medals and awards)
-
58th Annual SSC Meeting of the ISTH - Young Investigators Awards
Douxfils, J. (Recipient), 26 Jun 2012
Prize: Prize (including medals and awards)
-
Alfers 2022 - Prix de l'innovation
Douxfils, J. (Recipient), 24 May 2022
Prize: Prize (including medals and awards)
-
Eberhard F. Mammen Young Investigator Award 2019
Douxfils, J. (Recipient), 2019
Prize: National/international honour
Activities
-
Current Overview of the Cardiovascular Risk of Estetrol/Drospirenone versus Ethinylestradiol Containing Pills
Douxfils, J. (Speaker)
31 Aug 2026Activity: Talk or presentation types › Invited talk
-
Oral contraceptive: Are natural estrogens safer regarding thrombosis risk?
Douxfils, J. (Speaker)
14 Jul 2026Activity: Talk or presentation types › Invited talk
-
The Pharmacology and Safety of Estetrol
Douxfils, J. (Speaker)
5 Jul 2026Activity: Talk or presentation types › Invited talk
-
Natuurlijke oestrogenen in de combinatiepil: tijd voor verandering van de richtlijnen?
Douxfils, J. (Speaker)
9 Jun 2026Activity: Talk or presentation types › Invited talk
-
L’importance des oestrogènes naturels en contraception
Douxfils, J. (Speaker)
3 Jun 2026Activity: Talk or presentation types › Invited talk
Thesis
-
Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Douxfils, J. (Author), Dogne, J.-M. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (Jury), Verhamme, P. (Jury), TEN CATE, H. (Jury) & Ageno, W. (Jury), 24 Oct 2015Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
-
Therapeutic monitoring of new oral anticoagulant: focus on dabigatran
Douxfils, J. (Author), Dogne, J.-M. (Supervisor), 2012Student thesis: Master types › Master in Pharmacy
Press/Media
-
Studies from University of Namur in the Area of Life Science Described (Flow cytometry-based characterization of isolated human neutrophils: Evaluating viability, purity and defining a reference interval for basal activation in functional assays)
25/08/26
1 item of Media coverage
Press/Media: Expert Comment
-
Studies from University of Namur in the Area of Gene Therapy Reported [Rethinking hemocompatibility standards: a critical appraisal of current regulatory frameworks for Advanced Therapy Medicinal Products (ATMPs) validation]
17/08/26
1 item of Media coverage
Press/Media: Expert Comment
-
Reports from University of Namur Add New Data to Findings in Neoplasms (Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications)
25/05/26
1 item of Media coverage
Press/Media: Expert Comment
-
New Findings from University of Namur in the Area of Science Described (Techniques for measuring NETosis: A critical literature review and outlook for standardization)
Dogné, J.-M., Douxfils, J. & Mullier, F.
21/05/26
1 item of Media coverage
Press/Media: Expert Comment
-
Study Results from University of Namur Update Understanding of Thrombosis (Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies)
Dogné, J.-M., Douxfils, J. & Morimont, L.
24/04/26
1 item of Media coverage
Press/Media: Expert Comment